Skip to content
Unrated Drug recall · FDA · Published December 22, 2022

AVKARE Glycopyrrolate Tablets Recall: Unknown Impurities Risk

AVKARE LLC recalls 1 mg Glycopyrrolate tablets due to unspecified impurities. Consumers with Rx-only unit dose cartons from Pulaski, TN (NDC 50268-363-15) should check lot numbers 43313 or 43342.

🇺🇸 FDA recall #D-0091-2023DrugAVKARE ›
Take action

Contact the company

Recalling firmAVKARE LLC615 N 1st St · Pulaski, TN 38478-2403
✎ GovInfoNow plain-language explainer

AVKARE LLC is recalling 1 mg Glycopyr: 50-tablet unit dose cartons (Rx only) made in Pulaski, TN. The recall is due to unknown impurities that could affect safety. This is a medication recall for prescription use only. Read more at govinfonow.com/recall/34159-avkare-glycopyrrolate-tablets-recall-unknown-impurities-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/34159-avkare-glycopyrrolate-tablets-recall-unknown-impurities-risk · Updated August 18, 2026 · FDA enforcement record: FDA #D-0091-2023

Cite this page

“AVKARE Glycopyrrolate Tablets Recall: Unknown Impurities Risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/34159-avkare-glycopyrrolate-tablets-recall-unknown-impurities-risk. Based on FDA recall #D-0091-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0091-2023%22&limit=1).

The FDA announced on 2022-12-22 that AVKARE LLC voluntarily recalled Glycopyrrolate Tablets, USP, 1 mg due to failed impurities and degradation specifications. The recall affects 1,237 cartons distributed nationwide.

How to tell if you have it

  • Brand: AVKARE
  • Product: Glycopyrrolate Tablets, USP, 1 mg, 50 Tablets (5x10) Unit Dose carton
  • NDC: 50268-363-15
  • Lot codes: 43313, 43342
  • Expiration date: 12/2023
  • Distribution: USA Nationwide

The hazard

The recalled tablets are out of specification for unknown impurities. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show AVKARE LLC has two other recalls on record since 2023-06-13. On 2023-08-11, the company recalled Sodium Fluoride Toothpaste due to wrong labeling risk. Other recent recalls of similar products include Novadoz Glycopyrrolate Oral Solution Recall (2025-12-15), AvKARE Rosuvastatin Tablets 10mg Recall (2025-12-31), and Sun Pharmaceutical Fluocinolone Acetonide Solution Recall (2025-12-30).

How to tell if you have this one

Check for the unit dose carton labeled 'Glycopyrrolate Tablets, USP, 1 mg, 50 Tablets (5x10)' with NDC 50268-363-15. Look for lot numbers 43313 or 43342 from the manufacturing date in Pulaski, TN.

  • Brand
    AVKARE
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Identify the NDC number 50268-363-15 and lot numbers 43313 or 43342 on the unit dose carton.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 13 days after the firm started it.

1. Firm started the recall: Dec 22, 202212. FDA classified it Class II: Dec 28, 202223. Published in FDA’s Enforcement Report: Jan 4, 2023320222023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0091-2023 (December 22, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0091-2023 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA